Lizhu Medicine (01513.HK): As of the end of August, a total of 13.383 million A shares have been repurchased.

Zhtng Cijng APP News, Lee's Pharmaceutical (01513.HK) announced that, as of August 31, 2025, the company has repurchased a total of 13.383 million shares of A-shares through centralized bidding trading, accounting for 1.48% of the company's total share capital. The highest purchase price was RMB 41.99 per share, and the lowest price was RMB 33.21 per share, with a total amount of RMB 491 million being used for the repurchase (excluding transaction costs).